menu
Research
Today's research for tomorrow's cure
Our Science
Research Groups
Facilities & Platforms
Clinical research
Find a researcher
Publications
Knowledge Transfer
Support us
Careers & study
Become a leader in cancer research
Vacancies
Faculty
Scientific staff
Scientific support staff
Postdoctoral fellows
PhD Students
Operational staff
Clinical fellows
Life in Amsterdam
Support us
News & Events
Check out our stories and backgrounds
News
Thematic collections
Media & Press
Calendar
Support us
About us
Maximum impact for cancer patients
Our vision
Organization
Collaborations
Responsible Research
Support us
Visit us
Contact us
Support us
Support us
Search
Support us
RESEARCH
PUBLICATIONS
COMBINATION THERAPY WITH CRIZOTINIB AND VINBLASTINE FOR RELAPSED OR REFRACTORY PEDIATRIC ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA.
Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.
Show more authors
+ 10
Fabian Knörr
Kim P J Schellekens
Reineke A Schoot
Judith Landman-Parker
Heiko-Manuel Teltschik
Jan Förster
Amambay Riquelme
Alwin D R Huitema
Natasha K A Van Eijkelenburg
Auke Beishuizen
C Michel Zwaan
Wilhelm Woessmann
Jasper Van der Lugt
More about this publication
Haematologica
Volume 108
Issue nr. 5
Pages 1442-1446
Publication date 01-05-2023
Full text links
Publisher website (DOI)
10.3324/haematol.2022.281896
Europe PubMed Central
36519329
Pubmed
36519329
Disclaimer
Privacy statement
Cookies
This site uses cookies
This website uses cookies to ensure you get the best experience on our website.